IDEAS home Printed from https://ideas.repec.org/a/plo/pntd00/0009606.html
   My bibliography  Save this article

Cost-effectiveness of dengue vaccination in Puerto Rico

Author

Listed:
  • Guido España
  • Andrew J Leidner
  • Stephen H Waterman
  • T Alex Perkins

Abstract

An effective and widely used vaccine could reduce the burden of dengue virus (DENV) around the world. DENV is endemic in Puerto Rico, where the dengue vaccine CYD-TDV is currently under consideration as a control measure. CYD-TDV has demonstrated efficacy in clinical trials in vaccinees who had prior dengue virus infection. However, in vaccinees who had no prior dengue virus infection, the vaccine had a modestly elevated risk of hospitalization and severe disease. The WHO therefore recommended a strategy of pre-vaccination screening and vaccination of seropositive persons. To estimate the cost-effectiveness and benefits of this intervention (i.e., screening and vaccination of seropositive persons) in Puerto Rico, we simulated 10 years of the intervention in 9-year-olds using an agent-based model. Across the entire population, we found that 5.5% (4.6%-6.3%) of dengue hospitalizations could be averted. However, we also found that 0.057 (0.045–0.073) additional hospitalizations could occur for every 1,000 people in Puerto Rico due to DENV-naïve children who were vaccinated following a false-positive test results for prior exposure. The ratio of the averted hospitalizations among all vaccinees to additional hospitalizations among DENV-naïve vaccinees was estimated to be 19 (13–24). At a base case cost of vaccination of 382 USD, we found an incremental cost-effectiveness ratio of 122,000 USD per QALY gained. Our estimates can provide information for considerations to introduce the CYD-TDV vaccine in Puerto Rico.Author summary: The first dengue vaccine, known as CYD-TDV, is currently under consideration as a public health tool in Puerto Rico, where dengue is endemic. Although the vaccine protects individuals with prior exposure to dengue virus, individuals vaccinated without prior dengue virus infection could experience a higher chance of severe disease. To avoid vaccinating individuals who have not been exposed to dengue virus, screening for prior infection before vaccination is recommended. Understanding the potential impacts of this intervention in specific settings can help public health decision makers to balance economic and health benefits to consider the implementation of this vaccine. In this study, we estimated the impacts of incorporating screening and vaccination in Puerto Rico for the next 10 years. We found that the vaccine could have a positive impact in reducing severe dengue by preventing 5.5% of hospitalizations, but it could also cause 1.6 hospitalizations for every 1,000 vaccinated who had a false-positive screening result. We also found that this intervention could be cost-effective in Puerto Rico at a cost of 382 USD.

Suggested Citation

  • Guido España & Andrew J Leidner & Stephen H Waterman & T Alex Perkins, 2021. "Cost-effectiveness of dengue vaccination in Puerto Rico," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 15(7), pages 1-15, July.
    • Handle: RePEc:plo:pntd00:0009606
    DOI: 10.1371/journal.pntd.0009606
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009606
    Download Restriction: no
    File URL: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009606&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pntd.0009606?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Leigh R Bowman & Sarah Donegan & Philip J McCall, 2016. "Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 10(3), pages 1-24, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Juliana Quintero & Nicolás Ronderos Pulido & James Logan & Thomas Ant & Jane Bruce & Gabriel Carrasquilla, 2020. "Effectiveness of an intervention for Aedes aegypti control scaled-up under an inter-sectoral approach in a Colombian city hyper-endemic for dengue virus," PLOS ONE, Public Library of Science, vol. 15(4), pages 1-16, April.
    2. Antonio Ligsay & Olivier Telle & Richard Paul, 2021. "Challenges to Mitigating the Urban Health Burden of Mosquito-Borne Diseases in the Face of Climate Change," IJERPH, MDPI, vol. 18(9), pages 1-12, May.
    3. Renaud Marti & Zhichao Li & Thibault Catry & Emmanuel Roux & Morgan Mangeas & Pascal Handschumacher & Jean Gaudart & Annelise Tran & Laurent Demagistri & Jean-François Faure & José Joaquín Carvajal & , 2020. "A Mapping Review on Urban Landscape Factors of Dengue Retrieved from Earth Observation Data, GIS Techniques, and Survey Questionnaires," Post-Print hal-02682042, HAL.
    4. Auliya A. Suwantika & Angga P. Kautsar & Woro Supadmi & Neily Zakiyah & Rizky Abdulah & Mohammad Ali & Maarten J. Postma, 2020. "Cost-Effectiveness of Dengue Vaccination in Indonesia: Considering Integrated Programs with Wolbachia -Infected Mosquitos and Health Education," IJERPH, MDPI, vol. 17(12), pages 1-15, June.
    5. David Weetman & Basile Kamgang & Athanase Badolo & Catherine L. Moyes & Freya M. Shearer & Mamadou Coulibaly & João Pinto & Louis Lambrechts & Philip J. McCall, 2018. "Aedes Mosquitoes and Aedes -Borne Arboviruses in Africa: Current and Future Threats," IJERPH, MDPI, vol. 15(2), pages 1-20, January.
    6. Christopher Fitzpatrick & Alexander Haines & Mathieu Bangert & Andrew Farlow & Janet Hemingway & Raman Velayudhan, 2017. "An economic evaluation of vector control in the age of a dengue vaccine," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 11(8), pages 1-27, August.
    7. Dyna Doum & Hans J. Overgaard & Mayfong Mayxay & Sutas Suttiprapa & Prasert Saichua & Tipaya Ekalaksananan & Panwad Tongchai & Md. Siddikur Rahman & Ubydul Haque & Sysavanh Phommachanh & Tiengkham Pon, 2020. "Dengue Seroprevalence and Seroconversion in Urban and Rural Populations in Northeastern Thailand and Southern Laos," IJERPH, MDPI, vol. 17(23), pages 1-19, December.
    8. Martinez-Cruz, Carolina & Arenas-Monreal, Luz & Gomez-Dantes, Héctor & Villegas-Chim, Josue & Barrera-Fuentes Gloria, Abigail & Toledo-Romani Maria, Eugenia & Pavia-Ruz, Norma & Che-Mendoza, Azael & M, 2023. "Educational intervention for the control of Aedes aegypti with Wolbachia in Yucatan, Mexico," Evaluation and Program Planning, Elsevier, vol. 97(C).
    9. Jian-Wei Xu & Hui Liu & Didan Ai & Yan Yu & Bian Yu, 2019. "The Shan people’s health beliefs, knowledge and perceptions of dengue in Eastern Shan Special Region IV, Myanmar," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 13(6), pages 1-15, June.
    10. Claudia Buhler & Volker Winkler & Silvia Runge-Ranzinger & Ross Boyce & Olaf Horstick, 2019. "Environmental methods for dengue vector control – A systematic review and meta-analysis," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 13(7), pages 1-15, July.
    11. Beniamino Caputo & Mattia Manica & Gianluca Russo & Angelo Solimini, 2020. "Knowledge, Attitude and Practices towards the Tiger Mosquito Aedes Albopictus. A Questionnaire Based Survey in Lazio Region (Italy) before the 2017 Chikungunya Outbreak," IJERPH, MDPI, vol. 17(11), pages 1-12, June.
    12. Antonio D. Ligsay & Kristan Jela M. Tambio & Michelle Joyce M. Aytona & Grecebio Jonathan D. Alejandro & Zypher Jude G. Regencia & Emmanuel S. Baja & Richard Edward L. Paul, 2022. "Assessing Entomological and Epidemiological Efficacy of Pyriproxyfen-Treated Ovitraps in the Reduction of Aedes Species: A Quasi-Experiment on Dengue Infection Using Saliva Samples," IJERPH, MDPI, vol. 19(5), pages 1-13, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pntd00:0009606. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosntds (email available below). General contact details of provider: https://journals.plos.org/plosntds/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.